Title Cardiolipin Remodeling by ALCAT1 Links Oxidative Stress and Mitochondrial Dysfunction to Obesity
Authors Li, Jia
Romestaing, Caroline
Han, Xianlin
Li, Yuan
Hao, Xinbao
Wu, Yinyuan
Sun, Chao
Liu, Xiaolei
Jefferson, Leonard S.
Xiong, Jingwei
LaNoue, Kathryn F.
Chang, Zhijie
Lynch, Christopher J.
Wang, Huayan
Shi, Yuguang
Affiliation Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.
NW A&F Univ, Shaanxi Ctr Stem Cell Engn & Technol, Yangling, Shaanxi, Peoples R China.
Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA.
Tsinghua Univ, Sch Med, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.
Keywords FATTY-ACID OXIDATION
COMPLEX-I ACTIVITY
INSULIN-RESISTANCE
SKELETAL-MUSCLE
DOCOSAHEXAENOIC ACID
LIPID-PEROXIDATION
SHOTGUN LIPIDOMICS
PPAR-GAMMA
ROSIGLITAZONE
HEART
Issue Date 2010
Publisher cell metabolism
Citation CELL METABOLISM.2010,12,(2),154-165.
Abstract Oxidative stress causes mitochondrial dysfunction and metabolic complications through unknown mechanisms. Cardiolipin (CL) is a key mitochondrial phospholipid required for oxidative phosphorylation. Oxidative damage to CL from pathological remodeling is implicated in the etiology of mitochondrial dysfunction commonly associated with diabetes, obesity, and other metabolic diseases. Here, we show that ALCAT1, a lyso-CL acyltransferase upregulated by oxidative stress and diet-induced obesity (DIO), catalyzes the synthesis of CL species that are highly sensitive to oxidative damage, leading to mitochondrial dysfunction, ROS production, and insulin resistance. These metabolic disorders were reminiscent of those observed in type 2 diabetes and were reversed by rosiglitazone treatment. Consequently, ALCAT1 deficiency prevented the onset of DIO and significantly improved mitochondrial complex I activity, lipid oxidation, and insulin signaling in ALCAT1(-/-) mice. Collectively, these findings identify a key role of ALCAT1 in regulating CL remodeling, mitochondrial dysfunction, and susceptibility to DIO.
URI http://hdl.handle.net/20.500.11897/242559
ISSN 1550-4131
DOI 10.1016/j.cmet.2010.07.003
Indexed SCI(E)
Appears in Collections: 分子医学研究所

Web of Science®


188

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.